For uninsured or self-paying patients, the new $199 introductory pricing through NovoCare Pharmacy and GoodRx provides significant savings compared to the full retail price of approximately $1,000
GLP-1 receptor agonists were more frequently associated with weight reduction, established atherosclerotic cardiovascular disease, and inadequate glycemic control
A total of 484 patients with a mean duration of diabetes of 8.1 years were randomised to receive lixisenatide 20 g OD ( n = 323) or placebo ( n = 161) with a two-step dose increase, in combination with pioglitazone, for the main double-blind treatment period of 24 weeks, followed by a variable double-blind extension of at least 52 weeks
Book Now with our Registered Nurse Injectors Tab Content This is a basic text element
Orderly Meds sources from such compounding operations, giving patients access to GLP-1 therapy at a fraction of brand-name pricing